fig6

Figure 6. Association of pediatric patient outcomes with FGFR gene family expression levels. Using the Kocak dataset from the R2 Genomics Analysis and Visualization Platform^[19] (http://r2.amc.nl; accessed on 10/15/2024), Kaplan-Meier curves were generated and downloaded depicting overall survival (OS) among all neuroblastoma patients, separated by tumors with high expression (in red) vs. low expression (in blue) of FGFR1 (A); FGFR2 (B); FGFR3 (C); and FGFR4 (D), with patient numbers in parentheses. Using the Williamson and Dirksen datasets^[20,21] from the R2 Genomics Analysis and Visualization Platform (http://r2.amc.nl; accessed on 10/16/2024), Kaplan-Meier curves were generated and downloaded depicting overall survival (OS) among all with rhabdomyosarcoma (E-H) and Ewing sarcoma (I-L), separated by tumors with high expression (in red) vs. low expression (in blue) of FGFR1 (E,I), FGFR2 (F,J), FGFR3 (G,K), and FGFR4 (H,L), with patient numbers in parentheses. FGFR: fibroblast growth factor receptor.